Boehringer Ingelheim to submit nerandomilast for IPF treatment approval
Ingelheim, Germany- September 2024- Boehringer Ingelheim announced that the FIBRONEER™-IPF trial met…
Search
Have an existing account?
Sign In
Tag: nerandomilast